BIO-key International (BKYI) Stock Price, News & Analysis

Company Overview

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

Key Stats

• Today's Range: $1.00 to $1.07
• 50-Day Range: $0.87 to $2.38
• 52-Week Range: $0.52 to $3.68
• Volume: 229,954 shs
• Average Volume: 185,744 shs
• Market Capitalization: $3.22 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BKYI Stock Analysis - Frequently Asked Questions

How have BKYI shares performed this year?

BIO-key International's stock was trading at $1.71 at the beginning of the year. Since then, BKYI stock has decreased by 39.8% and is now trading at $1.03.
View the best growth stocks for 2025 here.

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) released its quarterly earnings results on Wednesday, August, 14th. The technology company reported ($1.00) earnings per share for the quarter, missing analysts' consensus estimates of ($0.54) by $0.46. The technology company earned $1.14 million during the quarter. BIO-key International had a negative net margin of 72.53% and a negative trailing twelve-month return on equity of 3,124.77%.

When did BIO-key International's stock split?

BIO-key International's stock reverse split on the morning of Thursday, December 21st 2023. The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Who are BIO-key International's major shareholders?

Top institutional investors of BIO-key International include Concourse Financial Group Securities Inc.. Insiders that own company stock include James David Sullivan and Michael W Depasquale.
View institutional ownership trends.

How do I buy shares of BIO-key International?

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BIO-key International investors own include Exxon Mobil (XOM), Onconova Therapeutics (ONTX), T2 Biosystems (TTOO), Nokia Oyj (NOK), Electrameccanica Vehicles (SOLO), Tonix Pharmaceuticals (TNXP) and iBio (IBIO).

Company Calendar

• Last Earnings: 8/14/2024
• Today: 2/22/2025
• Next Earnings (Estimated): 3/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Prepackaged software
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:BKYI
• CUSIP: N/A
• CIK: 1019034
• Web: www.bio-key.com
• Phone: (732) 359-1100
• Fax: 732-359-1101
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-8,520,000.00
• Net Margins: -72.53%
• Pretax Margin: -76.33%
• Return on Equity: -3,124.77%
• Return on Assets: -106.39%

Debt

• Debt-to-Equity Ratio: 0.63
• Current Ratio: 0.78
• Quick Ratio: 0.71

Sales & Book Value

• Annual Sales: $7.76 million
• Price / Sales: 0.42
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.03 per share
• Price / Book: 1.00

Miscellaneous

• Outstanding Shares: 3,130,000
• Free Float: 2,946,000
• Market Cap: $3.22 million
• Optionable: No Data
• Beta: -0.02